Liverpool Lane LLC

On this episode of the #HealthDistilled podcast, Andrew Steen talks to Northern Kentucky native Chris Nicholson. They talk about Chris leaving his job at Humana to co-found mPulse Mobile in Los Angeles. And he shares some thoughts on the #healthtech scene in Louisville. Full episode -> https://lnkd.in/eHRCWap2 #HealthTech #HealthcareInnovation

Black Friday is a great opportunity to catch up on #HealthDistilled podcast episodes! A focus of Health Distilled is to spotlight the diaspora of Kentuckians who have ventured outside the Commonwealth and work in various segments of the healthcare industry. ☕ shops get named. And 🥃 brands. It’s health, distilled.

"David opens with the weekly venture update then interviews John D. Cooper, CFA who leads Catalyst by Wellstar, the corporate venture arm of Wellstar Health System." 

Merrill Anovick and Shawn Dastmalchi joined Vic Gatto of Jumpstart Capital, a Gratia Health investor, to discuss the crisis we're facing in the nursing profession. In partnership with ScionHealth, Gratia is helping hospitals better compensate, reward, and develop nurses leading to happier employees and better care outcomes. 

"With renewed focus on innovation, Cincinnati Children's is building new tools and processes to help frontline workers tackle unmet clinical needs."

"Given the growing momentum around #ICHRA, [Christina Farr] teamed up with two colleagues - Tracy Massel and Michael Kolber - both insurance and health policy experts, to explore this topic through the lens of a set of important questions."

At the heart of Apellis is our belief that exceptional science and compassion are equally valued. Learn more about what it means to be an Apellucian. #WeAreApellis 

"An explosion of cell and gene therapies coming to market offers life changing, lifesaving treatments, but state #Medicaid programs face unique coverage, reimbursement, and administrative hurdles that limit access to these therapies for their enrollees," write Tracy Massel and Patricia Boozang.

🤩

Kentucky, y'all might remember that Poseida Therapeutics, Inc. was a spinout of Lexington-based Transposagen Biopharmaceuticals, which was itself acquired by Lonza.